USP22 and cancer: Indeed, treatment with the proteasomal inhibitor MG132, but not the lysosomal inhibitor chloroquine, fully rescued EZH2 protein expression in cancer cells either with Usp22 deletion or treated with the USP22 small-molecule inhibitor S02 (Figure 3D and Supplemental Figure 7D).